Los Angeles Biotechnology Network
GOOGLE Advertise With Biotech Networks
  • Home
  • About
  • News
    • All LABN News
    • Trending LABN News
  • Jobs
    • All LABN Jobs
    • Post A Job
  • Advertise
  • BN Connect
    • About Biotech Networks Connect
    • BN Connect
  • Subscribe
  • Contact
News Ticker
  • [ October 13, 2026 ] Nationally Recognized Cardiac Surgeon Anthony D. Caffarelli, M.D., Joins MemorialCare as Chief of Cardiac Surgery, MemorialCare Heart & Vascular Institute Los Angeles Biotech News
  • [ October 12, 2026 ] Bringing justice and transparency to the reporting of jail deaths in Riverside County   Los Angeles Biotech News
  • [ October 12, 2026 ] M&A Healthcare Advisors Advises Innovo Detox on Sale to R&S Holdings, Inc. Los Angeles Biotech News
  • [ October 12, 2026 ] Dr. Dayan Goodenowe Takes the Cover of TopDoctor Magazine, Revealing a New Vision for the Future of Health Los Angeles Biotech News
  • [ October 12, 2026 ] Beverly Hills Psychologist Dr. Shannon Daneshrad Expands Practice to Meet Growing Demand for ADHD and Autism Evaluations and Couples Therapy Los Angeles Biotech News
HomeLos Angeles Biotech NewsAmgen drops $55M upfront for Rodeo Therapeutics and its prostaglandin blockers

Amgen drops $55M upfront for Rodeo Therapeutics and its prostaglandin blockers

March 30, 2021 Los Angeles Biotechnology Network News Los Angeles Biotech News Comments Off on Amgen drops $55M upfront for Rodeo Therapeutics and its prostaglandin blockers

Amgen drops $55M upfront for Rodeo Therapeutics and its prostaglandin blockers
aalidrus
Tue, 03/30/2021 – 17:07

Previous

Amgen takes a swing at regenerative immunology with $721M acquisition of Rodeo Therapeutics

Next

ChromaDex and the Citrin Foundation Announce Global Research Collaboration Exploring Citrin Deficiency

Follow/Subscribe

GOOGLE Advertise With Biotech Networks
POST A JOB
Advertise With Biotech Networks

Copyright © 2026 Biotech Networks, LLC

Get Weekly/Trending/Daily News & Jobs Delivered to Your Inbox